The Current Ratio as of December 2025 (TTM) for BrightPath Biotherapeutics Co., Ltd. (4594.T) is 12.43

According to BrightPath Biotherapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 12.43. This represents a change of 64.21% compared to the average of 7.57 of the last 4 quarters.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Historical Current Ratio (quarterly & annually)

How has 4594.T Current Ratio performed in the past?

The mean historical Current Ratio of BrightPath Biotherapeutics Co., Ltd. over the last ten years is 21.20. The current 12.43 Current Ratio has changed 5.76% with respect to the historical average. Over the past ten years (40 quarters), 4594.T's Current Ratio was at its highest in in the June 2017 quarter at 49.83. The Current Ratio was at its lowest in in the December 2023 quarter at 2.31.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BrightPath Biotherapeutics Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Average Current Ratio

How has 4594.T Current Ratio performed in the past?

The current Current Ratio of BrightPath Biotherapeutics Co., Ltd. (4594.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BrightPath Biotherapeutics Co., Ltd. (4594.T) Current Ratio vs. Peers

How is 4594.T’s Current Ratio compared to its peers?

BrightPath Biotherapeutics Co., Ltd.’s Current Ratio is greater than ADR120S, Inc. (5.44), greater than OncoTherapy Science, Inc. (4.06), less than K Pharma,Inc. (19.41), less than Noile-Immune Biotech Inc. (69.34), less than TMS Co., Ltd. (26.11), greater than PRISM BioLab Co.,LTD (4.64), greater than Linical Co., Ltd. (1.55), greater than Chiome Bioscience Inc. (4.72), greater than Kohjin Bio Co., Ltd. (1.83), less than MedRx Co., Ltd (28.01),

Build a custom stock screener for BrightPath Biotherapeutics Co., Ltd. (4594.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BrightPath Biotherapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BrightPath Biotherapeutics Co., Ltd. (4594.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BrightPath Biotherapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.